DiscoverFew & Far Between: Conversations from the Front Lines of Drug DevelopmentEpisode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio
Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

Update: 2025-04-03
Share

Description

How do you turn back the epigenetic clock for humans and their animal companions? 


Host Chris O'Brien welcomes Dan Oliver, CEO and Founder of Rejuvenate Bio, to the podcast. Tune in as we take a deep dive into parallel clinical trials designed to address chronic, age-related diseases in people and their pets. Plus, we'll zoom in on the right corporate structure for biotech products and the benefits of brainstorming.


Listen in to the latest episode of the Few & Far Between podcast today!


 

Comments 
In Channel
Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech

Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech

2025-09-0343:41

Episode 58: Jerry McLaughlin, CEO and Board Member at Life Biosciences

Episode 58: Jerry McLaughlin, CEO and Board Member at Life Biosciences

2025-08-1444:43

Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation

Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation

2025-07-2244:53

Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

2025-07-1539:28

Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®

Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®

2025-07-0938:46

Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

2025-05-2845:11

Episode 53: Frank David, Founder and Managing Director, Pharmagellan

Episode 53: Frank David, Founder and Managing Director, Pharmagellan

2025-04-2950:46

Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI

Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI

2025-04-2352:05

Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

2025-04-0355:05

Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova

Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova

2025-03-1852:02

Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health

Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health

2025-02-2735:37

Episode 48: John Celebi, President and CEO, Sensei Bio

Episode 48: John Celebi, President and CEO, Sensei Bio

2025-02-1838:46

Episode 46: Ben Olds and Amy Fenollosa, Haven Human Asset Ventures

Episode 46: Ben Olds and Amy Fenollosa, Haven Human Asset Ventures

2025-01-1543:29

Episode 47 - Marc Lajoie, CEO at Outpace Bio

Episode 47 - Marc Lajoie, CEO at Outpace Bio

2024-12-3148:25

Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris

Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris

2024-12-1237:26

Episode 44: Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics

Episode 44: Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics

2024-10-2344:29

Episode 43: Isaac Stoner, Co-founder and CEO at Octagon Therapeutics

Episode 43: Isaac Stoner, Co-founder and CEO at Octagon Therapeutics

2024-09-1239:18

Episode 42: Diana Azzam, PhD, Assistant Professor at Florida International University, Co-Founder at First Ascent Biomedical

Episode 42: Diana Azzam, PhD, Assistant Professor at Florida International University, Co-Founder at First Ascent Biomedical

2024-07-1636:14

Episode 41: Craig Serra, Head of Clinical Research Scientific and Technical Engagement, Flatiron Health

Episode 41: Craig Serra, Head of Clinical Research Scientific and Technical Engagement, Flatiron Health

2024-05-2335:24

Episode 40: Professor Justin Stebbing, Editor-in-Chief, Oncogene journal

Episode 40: Professor Justin Stebbing, Editor-in-Chief, Oncogene journal

2024-04-2533:23

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

Chris O'Brien